Digital pathology slide scanner market seen topping $1.8 billion by 2030

The digital pathology slide scanner market is projected to grow from $1.04 billion in 2025 to $1.16 billion in 2026, according to The Business Research Company. Rising telepathology use, cancer diagnostics spending and demand for data-driven workflows are driving adoption across hospital and clinical labs.

Why it matters: - Digital pathology slide scanners are becoming more important as hospitals and labs shift from glass slides to digital workflows. - Faster digitization can improve remote collaboration, support precision diagnostics and expand access in areas with fewer pathology specialists. - The market’s growth also reflects broader pressure on healthcare systems to automate lab work and handle rising diagnostic volumes.

What happened: - The Business Research Company published a 2026 market report on the digital pathology slide scanner market on July 17, 2026. - The report values the market at $1.04 billion in 2025 and projects $1.16 billion in 2026. - The report forecasts the market will reach $1.82 billion by 2030. - The report cites North America as the largest market in 2025. - The report projects Europe as the fastest-growing region during the forecast period.

The details: - Digital pathology slide scanners convert physical pathology slides into high-resolution digital images for diagnostic analysis. - The scanners use optics and scanning technology to capture tissue details at multiple magnifications. - Digitized slides can be stored electronically, shared remotely and reviewed on computers for diagnosis, research and telepathology workflows. - The report links near-term growth to past constraints such as manual microscopy diagnosis, limited glass-slide storage, low-resolution scanners, expensive equipment, slow digital lab adoption and a shortage of skilled pathology staff in remote locations. - The report says future growth will be supported by telepathology adoption, precision medicine diagnostics, automation in hospital labs, data-driven diagnostic workflows and investment in cancer diagnostics infrastructure. - The report highlights several trends: remote pathology collaboration networks, standardized digital slide archiving and compliance, high-throughput clinical screening, stronger regulatory standards and quality assurance, and more ergonomic scanner designs. - The report’s regional coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report says its 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, market hotspot infographics and updated technology and trend analysis.

Between the lines: - The market forecast suggests digital pathology is moving from a specialist tool toward a broader clinical infrastructure layer. - Rising demand appears tied less to a single product cycle and more to structural shifts in healthcare delivery, including remote review and standardized digital records. - The emphasis on compliance, quality assurance and workflow integration points to a market that is maturing beyond simple image capture. - Cardiovascular disease is one demand driver, with the CDC reporting in October 2024 that cardiovascular diseases caused 919,032 U.S. deaths in 2023 and accounted for about one-third of all deaths. - The CDC also said coronary heart disease remained the leading cause, with about one in six cardiovascular deaths occurring among adults younger than 65.

What's next: - The market is expected to keep expanding through 2030 as telepathology and automated lab workflows spread. - Scanner makers will likely compete more on usability, throughput, compliance support and integration with digital lab systems. - Europe’s expected outperformance could signal faster adoption across more mature healthcare markets outside North America. - Download a free sample of the report - View the full market report

The bottom line: - Digital pathology slide scanners are moving into a higher-growth phase as healthcare systems push deeper into digital diagnostics, remote collaboration and automated lab operations.